FindTrial
Sign In

Clinical Effectiveness and Lower Limb Biomechanical Analysis Study of Acupuncture Treatment for Early to Mid-Stage Knee Osteoarthritis (KOA) with "Pain as the Guiding Point"

Clinical Effectiveness and Lower Limb Biomechanical Analysis Study of Acupuncture Treatment for Early to Mid-Stage Knee Osteoarthritis (KOA) with "Pain as the Guiding Point"

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300073707
Enrollment
Unknown
Registered
2023-07-19
Start date
2023-07-19
Completion date
Unknown
Last updated
2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

knee osteoarthritis

Interventions

The control group for routine acupuncture treatment :The control group for routine acupuncture treatment was selected using commonly used acupoints for knee osteoarthritis (KOA) treatment as described
The acupuncture treatment group based on the "pain as the guiding point" theory:In the acupuncture treatment group based on the "pain as the guiding point" theory, the distribution pattern of painful

Sponsors

First Teaching Hospital of Tianjin University of Traditional Chinese Medicine Tianjin
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Select patients in the early to mid-stage of knee osteoarthritis (KOA) according to the diagnostic criteria. 2. Age range: 18 to 70 years (over 18 years at enrollment and under 65 years at the end of follow-up). 3. Preferably include patients with predominantly unilateral lesions. 4. Obtain informed consent and have the patients sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Patients with knee pain but with knee osteoarthritis (KOA) not being the primary cause. 2. Patients with severe diseases such as cardiovascular, cerebrovascular, hepatic, renal, and hematopoietic disorders. 3. Patients who have received other methods of KOA treatment within the past two weeks. 4. Patients with cardiovascular diseases, asthma, gastrointestinal disorders, bleeding disorders, ulcerative disorders, perioperative period, long-term alcohol consumption, or suspected or confirmed history of drug abuse, including those currently taking anticoagulant drugs (such as warfarin). 5. Pregnant, planning to become pregnant, or breastfeeding women, patients with mental disorders, etc. 6. Patients with a history of allergy to lidocaine hydrochloride. 7. Patients with pacemakers. 8. Patients deemed unsuitable for inclusion by consensus of the research team physicians due to other reasons.

Design outcomes

Primary

MeasureTime frame
Visual Analogue Scale/Score;Western Ontario and Mc-Master Universities Osteoarthritis Index;Osteoarthritis Knee and Hip Quality of Life;Detection of Pain Pressure Threshold (PPT) and Pain Tolerance Threshold (PTT) at Tender Points.;—

Countries

China

Contacts

Public ContactChao Zhang

First Teaching Hospital of Tianjin University of Traditional Chinese Medicine Tianjin

zhangchao2004.love@163.com+86 155 1099 2144

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026